Emv Capital Plc · LSE:EMVC

Emv Capital — NetScientific — Corporate Update (March 2024)

15 slides from Emv Capital's corporate update, Mar 19, 2024

  1. Slide 1: Business, Strategy and Portfolio Update

    Business, Strategy and Portfolio Update For the year ended 31 December 2023, and the period to date Dr Ilian Iliev, CEO 19 March 2024

  2. Slide 2: Disclaimer

    Disclaimer This presentation (and any information contained in any oral presentation accompanying it) (Presentation) has been prepared by NetScientific Plc (Company). This Presentation has not been approved by an authorised person in accordance with Section 21 of the Financial Services and Markets A

  3. Slide 3: Agenda

    Agenda Presentation • Introduction to NetScientific (NSCI) • Highlights of 2023 • Portfolio Highlights • Outlook: Strategy Update • Summary and Q&A 3

  4. Slide 4: About NetScientific

    About NetScientific NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies. • Identifying, investing in, and building high growth companies in the UK and internationally • Proactive commercial management of portfolio

  5. Slide 5: Advantages of Model

    Advantages of Model • Capital Efficient Investment Strategy: supporting portfolio companies with selective use of balance sheet • Proactive Portfolio Management: opens up value opportunities, investment on advantageous conditions • Value Creation Services: selective support to portfolio companies –

  6. Slide 6: Effective Board Leadership & Corporate Governance

    Effective Board Leadership & Corporate Governance Dr. Ilian Iliev, CEO Ed Hooper, Executive Director and Group General Counsel • Founder of EMV Capital – acquired by NetScientific PLC in 2020 • Former Partner of a City headquartered international law firm • Significant shareholder of NetScientific (

  7. Slide 7: Group Portfolio – Diversified Risk and Increased Investment Return Opportunities

    Group Portfolio – Diversified Risk and Increased Investment Return Opportunities 23 companies in Life Sciences, Deeptech and Sustainability segments VC and corporate finance firm NASDAQ-listed *Portfolio comprises of equity investments and exposure to companies through carried interest, realisable o

  8. Slide 8: Financial and Operational Highlights 2023

    Financial and Operational Highlights 2023 • Modest increase expected in Fair Value of the privately held assets as at 31 December 2023 • Across the Group's portfolio of 23 companies, an aggregate amount of c.£52.2 million raised through equity and venture debt by 13 companies • Significant increase

  9. Slide 9: Active Portfolio Management and Value Creation

    Active Portfolio Management and Value Creation CONTINUED SUPPORT THROUGH SUCCESSIVE STAGES • Concentrating on a “cohort” of companies, taking deeper stakes, with a focus on value creation and investment realisations • Selective new investments that align with our model, offer good value, and can ben

  10. Slide 10: Selected Portfolio Company Highlights

    Selected Portfolio Company Highlights ProAxsis Ltd, UK (medtech, respiratory Glycotest, Inc., US (liver cancer diagnostics, PDS Biotechnology Corp, NASDAQ: PDSB diagnostics, 81.9% direct, 8.7% CUA) 52.7% direct, 5.8% CUA) (Immuno-oncology, 3.5% direct) • Strengthened Board with appointment of Alan M

  11. Slide 11: Selected Portfolio Company Highlights

    Selected Portfolio Company Highlights Q-Bot, UK (robotics as a service, home retrofit Sofant Technologies, UK (semiconductors Vortex, US-UK (liquid biopsy, oncology, 22.1% insulation, 14.3% direct, 32.4% CUA) satellite comms, 1.4% direct, 25% CUA) direct, 15.4% CUA) • EMV Capital lead a £3.5m fundra

  12. Slide 12: Selected Portfolio Company Highlights

    Selected Portfolio Company Highlights Ventive Limited, UK (heat pumps and passive Deeptech Recycling Limited, UK (recycling, Martlet Capital, UK (early-stage deep tech and air ventilation, 10.9% direct, 24.9% CUA) 30% direct) life sciences investor, 1% direct, 5.9% CUA) • Secured c.£900,000 investme

  13. Slide 13: Outlook: Strategy Update

    Outlook: Strategy Update Grow the value of the NSCI stakes in portfolio companies: • Capital efficient investment in core companies • Active management • Provision of Value Creation Services Progress fund management practice: • Annual recurring revenue (management fees) • Carried interest potential

  14. Slide 14: Outlook: Strategy Update

    Outlook: Strategy Update Build a resilient, high-performance firm: • Developing team and operating platform • Scaling investment and fund management opportunities Achieve financial sustainability: • Moving to cover core operating costs through – operational income (corporate finance fees, value crea

  15. Slide 15: Summary - Q&A

    Summary - Q&A Advancing a Robust and Sustainable Business Model • Positioned to take advantage of the VC industry shift • Exploring opportunities to take on the management of two existing funds • Exit strategies being mapped for several portfolio companies • Align underlying asset value with market

NetScientific — Corporate Update (March 2024) on 6ix